Literature DB >> 16869127

[Smoke inhalation injury: diagnosis and respiratory management].

Hiroshi Ogura1, Yuka Sumi, Asako Matsushima, Yoshiki Tohma, Yoshiaki Inoue, Osamu Tasaki, Takeshi Shimazu, Hisashi Sugimoto.   

Abstract

Smoke inhalation is a significant comorbid factor following major thermal injury. Smoke exposure is only a trigger for the sequence of events responsible for the development of inhalation injury. Noxious chemicals generated by incomplete combustion injure the exposed bronchoepithelium and stimulate the release of chemical mediators that cause a progressive inflammatory process. Airway inflammation and pulmonary edema impair gas exchange and increase the susceptibility to pulmonary infection. Earlier diagnosis and treatment of inhalation injury is an important element to improve the clinical course of severe burn patients. The American Burn Association, however, recently concluded that there are insufficient data to support a treatment standard for the diagnosis of inhalation injury. At present, the diagnosis of inhalation injury is supported by the combination of history, physical examination, bronchoscopy, and laboratory findings For accurate diagnosis of inhalation injury, helical CT scanning and examination to detect activated leukocytes in bronchoalveolar lavage fluid may be warranted. In the respiratory management of inhalation injury, repeated removal of pseudomembrane by fiberoptic bronchoscopy and the use of adequate PEEP to avoid airway obstruction are essential. High-frequency percussive ventilation can be a suitable mode of ventilation for inhalation injury.

Entities:  

Mesh:

Year:  2005        PMID: 16869127

Source DB:  PubMed          Journal:  Nihon Geka Gakkai Zasshi        ISSN: 0301-4894


  3 in total

Review 1.  Smoke Inhalation Injury: Etiopathogenesis, Diagnosis, and Management.

Authors:  Kapil Gupta; Mayank Mehrotra; Parul Kumar; Anoop Raj Gogia; Arun Prasad; Joseph Arnold Fisher
Journal:  Indian J Crit Care Med       Date:  2018-03

Review 2.  Pathophysiology, research challenges, and clinical management of smoke inhalation injury.

Authors:  Perenlei Enkhbaatar; Basil A Pruitt; Oscar Suman; Ronald Mlcak; Steven E Wolf; Hiroyuki Sakurai; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

Review 3.  Preclinical and clinical studies of smoke-inhalation-induced acute lung injury: update on both pathogenesis and innovative therapy.

Authors:  Bingxin Guo; Yichun Bai; Yana Ma; Cong Liu; Song Wang; Runzhen Zhao; Jiaxing Dong; Hong-Long Ji
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.